The Design of Diagnostic Medical Facilities where ... - ResearchGate
The Design of Diagnostic Medical Facilities where ... - ResearchGate
The Design of Diagnostic Medical Facilities where ... - ResearchGate
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
e made as soon as possible. It should be noted that the processing <strong>of</strong> an application for a large or complex<br />
facility, such as a nuclear medicine department, may take several months from the time <strong>of</strong> first receipt <strong>of</strong> the<br />
draft plans to the issue <strong>of</strong> the licence. A licence must be obtained prior to any irradiating apparatus or<br />
radioactive substance being acquired by the undertaking.<br />
<strong>The</strong> following steps should be used as a guide for applicants when making an application for a licence for a<br />
new facility:<br />
• For practices involving the use <strong>of</strong> irradiating apparatus or radioactive sources/materials, the undertaking<br />
should advise the RPII <strong>of</strong> the proposal to build a new facility, or to modify an existing facility, as early in<br />
the project as possible.<br />
• <strong>The</strong> undertaking must appoint an approved RPA to the project at the outset to advise on all aspects <strong>of</strong><br />
radiation protection; a register <strong>of</strong> approved RPAs is maintained by the RPII. All communications between<br />
the project design/building team and the RPII on issues relating to radiation protection should be<br />
channelled through the appointed RPA. <strong>The</strong> role <strong>of</strong> the RPA is discussed further in Section 2.2.<br />
• In the case <strong>of</strong> large building projects a copy <strong>of</strong> the draft plans, as agreed between the RPA and undertaking,<br />
should be forwarded to the RPII for an initial review. <strong>The</strong> RPII may query or suggest modifications to the<br />
plans at this stage.<br />
• As the installation progresses and nears completion the RPA should assess the shielding in the installation<br />
and identify any discrepancies from the agreed plans which may affect radiation protection.<br />
• Prior to acquiring any source <strong>of</strong> ionising radiation e.g. irradiating apparatus, sealed or unsealed radioactive<br />
sources, a licence application form or licence amendment form (in the case <strong>of</strong> an existing licensee) for<br />
the proposed practices shall be obtained from the RPII.<br />
• <strong>The</strong> undertaking shall make an application for a new licence, or an amendment <strong>of</strong> an existing licence, by<br />
returning the completed form to the RPII. <strong>The</strong> application must be supported by both a risk assessment<br />
<strong>of</strong> potential exposures to workers and members <strong>of</strong> the public arising from the practice or from foreseeable<br />
accidents and a copy <strong>of</strong> the Radiation Safety Procedures to be used in the practice.<br />
• Provided that the RPII is satisfied with the application, a licence will be issued authorising the licensee to<br />
take custody <strong>of</strong> the licensed items. <strong>The</strong> use <strong>of</strong> the licensed items will be restricted solely to those tests<br />
necessary to commission the items.<br />
• Upon receipt by the RPII <strong>of</strong> a satisfactory RPA commissioning report for a new licensed item, the restriction<br />
on the licence relating to that item will be removed and an amended licence issued.<br />
<br />
<strong>The</strong> <strong>Design</strong> <strong>of</strong> <strong>Diagnostic</strong> <strong>Medical</strong> <strong>Facilities</strong> <strong>where</strong> Ionising Radiation is used